Company / Revenue
LeMaitre Vascular Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$249.6M
FY2025
5-year range
$129.4M / $249.6M
FY2021-FY2025
Trend
+13.5%
vs FY2024
Sector context
#138 of 156
Health Care
What the data says
LeMaitre Vascular's revenue of $250M is lower than 88% of companies in the Health Care sector (FY2025). Revenue has increased for 8 consecutive years, from $78M in FY2017 to $250M in FY2025.
Based on SEC 10-K filings.
$250M in FY2025 with a 5-year CAGR of +16.3%.
Improved from $193M to $250M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +17.4%
- 5-Year CAGR
- +16.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 156This company $249.6M Sector average $19.0B
▼
-98.7% below sector average
Key checks
Key Insights
- LeMaitre Vascular's revenue has grown for 8 consecutive years.
- 5-year CAGR of +16.3%, indicating consistent growth.
- In FY2025, revenue increased 13.5% year-over-year.
- Ranks #138 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $249.6M | +13.5% |
| FY2024 | $219.9M | +13.6% |
| FY2023 | $193.5M | +25.3% |
| FY2022 | $154.4M | +19.4% |
| FY2021 | $129.4M | +10.4% |
| FY2020 | $117.2M | +11.0% |
| FY2019 | $105.6M | +4.7% |
| FY2018 | $100.9M | +28.7% |
| FY2017 | $78.4M | -12.1% |
| FY2016 | $89.2M | +38.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026